EicOsis Human Health
CompanyUnited States
EicOsis Human Health develops one asset, in phase 1 (EC5026 in chronic kidney disease). Mostly small molecule; based in the United States.
- 1
- Asset
- Furthest stage
- Phase 1
- 6
- Trials
- 0
- Signals
Pipeline
1Soluble epoxide hydrolase (sEH) inhibitor
Phase 1, Small molecule, chronic kidney disease, degenerative disc disease
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials6
- Signals1
- Similar companies6